돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 229564생성일: 2026년 10월 24일

Acetate → Bupropion

https://huagongshe.com/ko/reaction/229564

반응식

참여 물질

역할이름HCID투입량
반응물AcetateHCID 175—
반응물PhosphateHCID 1061—
반응물Bupropion HydrochlorideHCID 62884—
반응물Bupropion HydrobromideHCID 11984562—
생성물BupropionHCID 444—

반응 단계

The dissolution of bupropion HBr formulations according to the invention were assessed in three USP-3 media, i.e., SGF pH 1.2, Acetate Buffer pH 4.5 and Phosphate Buffer pH 6.8 over a period of 16 hours. These results are contained in FIG. 66. Particularly Bupropion HBr XL 348 mg tablets (final), Lot # Bup-HBr-XL-012-5; Wellbutrin XL 300 mg tablets (final), Lot # 05A116; Bupropion HBr XL 348 mg tablets ECl Lot # Bup-HBr-XL-012-5 (EC 32 mg wg) and Wellbutrin XL 300 mg tablets (EC10-Lot # 05D047 were assessed in SGF media pH 1.2 for 2 hours, Acetate Buffer pH 4.5 for 2 hours, and Phosphate Buffer SIF pH 6.8 for a total of 10 hours. The results are contained in the FIG. 66-68.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07563823B2
출처 데이터셋uspto-grants-2009_07
ORD IDord-40e1bbce3083436c940deac123c8d01f
출처 메모uspto-grants-2009_07